SEC Form 4 · accession 0001209191-15-017442
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Charles Robb
Officer — Chief Financial Officer
Period of report
Feb 18, 2015
Accepted (ET)
Feb 23, 2015 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock option (right to buy)F1 | $3.29 | Feb 18, 2015 | A | 150,000 | A | — | Feb 18, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Exercisable ratably on each monthly anniversary of the date of grant over a four-year period.